Stock Photo newspapers
Press Release No. 7
/ April 22, 2009 /
Berlin

MPI and MDC Researchers Make Significant Strides in Identifying Cause of Bacterial Infections

Several bacterial pathogens use toxins to manipulate human host cells, ultimately disturbing cellular signal transduction. Until now, however, scientists have been able to track down only a few of the proteins that interact with bacterial toxins in infected human cells. Now, researchers of the Max Planck Institute of Biochemistry in Martinsried and the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch in Germany have identified 39 interaction partners of these toxins, using novel technology which allowed them to screen for large numbers of proteins simultaneously (Cell Host & Microbe, Vol. 5, Issue 4, 397-403)*.

Many
bacteria inject toxins into human cells using a secretion system that resembles
a molecular syringe. Within the host cell, some of these toxins are activated
in such a way that they can manipulate important cellular signaling pathways.
In healthy cells, these signals serve to regulate metabolism or cell division,
among other things. By manipulating the signals, bacteria can abuse the cell
machinery of the human host in order to spread and survive.

Applying a
method developed by Professor Matthias Mann of the MPI, the scientists
succeeded for the first time in systematically investigating the cellular target
sites of the bacterial toxins. “Surprisingly, the toxins are not optimally
adapted to the structures of human proteins,” Dr. Matthias Selbach of MDC
explained. While binding relatively weakly to individual human proteins, they
are able to influence several different proteins simultaneously. “A single bacterial
toxin seems to function like a master key that can access different host cell proteins
in parallel”, Dr. Selbach said. “Perhaps it is due to this strategy that
bacteria are able to attack very different cells and, thus, to increase their
survival chances in the host.”

Dr.
Selbach hopes that these basic research findings will help to improve the
treatment of bacterial infections in the future. Instead of nonspecific antibiotic
therapy, new drugs could target the signaling mechanisms which are disrupted by
the bacterial toxins.

*Host cell interactome of tyrosine-phosphorylated bacterial proteins

Matthias Selbach1,2, Florian Ernst Paul2, Sabine Brandt3, Patrick Guye4, Oliver Daumke2, Steffen Backert5, Christoph Dehio4, Matthias Mann1

1Max Planck Institute of Biochemistry, Dept. of Proteomics and Signal Transduction, Am Klopferspitz 18, D-82152 Martinsried, Germany

2Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, D-13092 Berlin, Germany

3Otto-von-Guericke University Magdeburg, Institute for Medical Microbiology, Leipziger Str. 44, D-39120 Magdeburg, Germany

4Biozentrum of the University of Basel, Focal Area Infection Biology, Klingelbergstrasse 70, CH-4056 Basel, Switzerland

5University College Dublin, School of Biomolecular and Biomedical Science, Ardmore House, Dublin-4, Ireland

Barbara
Bachtler

Press and PublicAffairs

MaxDelbrück
Center for Molecular Medicine (MDC)
Berlin-Buch

Robert-Rössle-Straße 10

13125 Berlin, Germany
Phone:
+49 (0) 30 94 06 - 38 96

Fax:  +49 (0) 30 94 06 - 38 33
e-mail:
presse@mdc-berlin.de

http://www.mdc-berlin.de/
 

Further information

Related news & events

Scientific image
© Felix Petermann, Max Delbrück Center
Press Release No. 29

Human and other primate hearts differ genetically

A team in the Hübner and Diecke Labs at the Max Delbrück Center have shown how human and non-human primate hearts differ genetically. The study, published in “Nature Cardiovascular Research,” reveals evolutionary adaptations in human hearts and provides new insights into cardiac disease.
Scientific image

Healthy organoids (left) show an organized neurogenic zone (shown in yellow) and neural progenitor cells (shown in red/pink). Huntington’s Disease organoids (right) exhibit almost no neural progenitors (red) and also show defects in cellular polarity (yellow). These defects have been described in the literature in human fetuses with Huntington’s disease.

© Selene Lickefett, Heinrich-Heine-Universität Düsseldorf, Werner Dykstra, Max Delbrück Center
Press Release No. 24

A new culprit in Huntington’s disease

Researchers in Berlin and Düsseldorf have implicated a new gene in the progression of Huntington’s disease in a brain organoid model. The gene may contribute to brain abnormalities much earlier than previously thought. The study was published in “Nature Communications.”
Wissenschaftliches Bild
© David Ausserhofer, Max Delbrück Center
Press Release No. 22

Sharpening the gene scissors together

The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from Nice have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for genetically determined diseases.
Waste water from Berlin in the laboratory

Wastewater sample before sequencing.

© Felix Petermann, MDC
Press Release No. 22

A vast viral world in wastewater

Deep metagenomic sequencing of wastewater in Berlin over 17 months shows this technique could help forecast disease outbreaks and monitor the spread of human pathogens. It can also reveal thousands of novel viruses, according to a study by the Landthaler lab published in “Environment International.”